Treatment of hyponatremia

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 5, 2010, Pages 493-498

  Sterns, Richard H ^a   Hix, John Kevin ^a   Silver, Stephen ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

hyponatremia; myelinolysis; syndrome of inappropriate antidiuretic hormone secretion; vasopressin; water intoxication

Indexed keywords

CONIVAPTAN; DESMOPRESSIN; SODIUM; SODIUM CHLORIDE; TOLVAPTAN;

BRAIN DAMAGE; BRAIN EDEMA; FALLING; FRACTURE; GAIT DISORDER; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; REVIEW; SODIUM BLOOD LEVEL; WATER INTOXICATION;

ANIMALS; DEAMINO ARGININE VASOPRESSIN; HUMANS; HYPONATREMIA; SODIUM; VASOPRESSINS;

EID: 77955919535     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32833bfa64     Document Type: Review

References (49)

1. Gankam Kengne F, Andres C, Sattar L, et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 2008; 101:583-588.
2. Sandhu HS, Gilles E, DeVita MV, et al. Hyponatremia associated with large-bone fracture in elderly patients. Int Urol Nephrol 2009; 41:733-737.
3. Kinsella S, Moran S, Sullivan MO, et al. Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol 2010; 5:275-280.
4. Verbalis JG, Barsony J, Sugimura Y, et al. Hyponatremia-induced osteoporo-sis. J Bone Miner Res 2010; 25:554-563.
5. Shapiro D, Sonnenblick M, Galperin I, et al. Severe hyponatraemia in elderly hospitalized patients: prevalence, aetiology and outcome. Intern Med J. [EPub ahead of print]
6. Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 2009; 122:857-865.
7. Whelan B, Bennett K, O'Riordan D, Silke B. Serum sodium as a risk factor for in-hospital mortality in acute unselected general medical patients. QJM 2009; 102:175-182.
8. Wald R, Jaber BL, Price LL, et al. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 2010; 170:294-302.
9. Schrier RW. Does 'asymptomatic hyponatremia' exist? Nat Rev Nephrol 2010; 6:185.
10. Decaux G. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Semin Nephrol 2009; 29:239-256.
11. Greenberg A, Lehrich RW. Treatment of chronic hyponatremia: now we know how, but do we know when or if? J Am Soc Nephrol 2010; 21:552-555.
12. Berl T, Quittnat-Pelletier F, Verbalis JG, et al. Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol 2010; 21:705-712.
13. Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006; 119:71.e1-71.e8.
14. Mount DB. The brain in hyponatremia: both culprit and victim. Semin Nephrol 2009; 29:196-215.
15. Dvir D, Beigel R, Hoffmann C. Hyponatremic brain edema: correlation with serial computed tomography scans. Isr Med Assoc J 2009; 11:442-443.
16. Koczmara C, Wade AW, Skippen P, et al. Hospital-acquired acute hypona-tremia and reports of pediatric deaths. Dynamics 2010; 21:21-26.
17. Bailey AG, McNaull PP, Jooste E, Tuchman JB. Perioperative crystalloid and colloid fluid management in children: where are we and how did we get here? Anesth Analg 2010; 110:375-390.
18. Hanna M, Saberi MS. Incidence of hyponatremia in children with gastroenteritis treated with hypotonic intravenous fluids. Pediatr Nephrol. [Epub ahead of print]
19. Moritz ML, Ayus JC. Improving intravenous fluid therapy in children with gastroenteritis. Pediatr Nephrol. [Epub ahead of print]
20. Rosner MH. Exercise-associated hyponatremia. Semin Nephrol 2009; 29:271-281.
21. Campbell GA, Rosner MH. The agony of ecstasy: MDMA (3,4-methylene- dioxymethamphetamine) and the kidney. Clin J Am Soc Nephrol 2008; 3:1852-1860.
22. Morita S, Inokuchi S, Yamamoto R, et al. Risk factors for rhabdomyolysis in self-induced water intoxication (SIWI) patients. J Emerg Med 2010; 38:293-296.
23. Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol 2009; 29:282-299.
24. Strandvik GF. Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure. Anaesthesia 2009; 64:990-1003.
25. Rockswold GL, Solid CA, Paredes-Andrade, et al. Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen. Neurosurgery 2009; 65:1035-1041; discussion 1041-1 042.
26. Rosner MH. Hyponatremia in patients with central nervous system disorders. Int J Clin Pract 2009; 63:348-350.
27. Woo CH, Rao VA, Sheridan W, Flint AC. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia. Neurocrit Care 2009; 11:228-234.
28. Palmer BF. Hyponatremia in the intensive care unit. Semin Nephrol 2009; 29:257-270.
29. Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol 2008; 19:194-196.
30. Yee AH, Burns JD, Wijdicks EF. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin North Am 2010; 21:339-352.
31. Norenberg MD. Central pontine myelinolysis: historical and mechanistic considerations. Metab Brain Dis 2010; 25:97-106.
32. Roh JH, Kim JH, Oh K, et al. Cortical laminar necrosis caused by rapidly corrected hyponatremia. J Neuroimaging 2009; 19:185-187.
33. Howard SA, Barletta JA, Klufas RA, et al. Best cases from the AFIP: osmotic demyelination syndrome. Radiographics 2009; 29:933-938.
34. Odier C, Nguyen DK, Panisset, M. Central pontine and extrapontine myeli-nolysis: from epileptic and other manifestations to cognitive prognosis. J Neurol. [Epub ahead of print].
35. Berl T, Rastegar A. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion. Am J Kidney Dis 2010; 55:742-748.
36. Gankam Kengne F, Soupart A, Pochet R, et al. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int 2009; 76:614-621.
37. Mount DB, Krahn TA. Hyponatremia: case vignettes. Semin Nephrol 2009; 29:300-317.
38. Sterns RH, Hix JK. Overcorrection of hyponatremia is a medical emergency. Kidney Int 2009; 76:587-589.
39. Hijab S, Havalad S, Snyder AK. The role of organic osmolytes in the response of cultured astrocytes to hyperosmolarity. Am JTher. [Epub ahead of print]
40. Naik KR, Saroja AO. Seasonal postpartum hypernatremic encephalopathy with osmotic extrapontine myelinolysis and rhabdomyolysis. J Neurol Sci 2010; 291:5-11.
41. Mohmand HK, Issa D, Ahmad Z, et al. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol 2007; 2:1110-1117.
42. Halperin ML, Kamel KS. A new look at an old problem: therapy of chronic hyponatremia. Nat Clin Pract Nephrol 2007; 3:2-3.
43. Perianayagam A, Sterns RH, Silver SM, et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol 2008; 3:331-336.
44. Sterns RH, Hix JK, Silver S. Treating profound hyponatremia: A strategy for controlled correction. Am J Kid Dis (in press).
45. Nguyen MK. Quantitative approaches to the analysis and treatment of the dysnatremias. Semin Nephrol 2009; 29:216-226.
46. Velez JC, Dopson SJ, Sanders DS, et al. Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experi ence. Nephrol Dial Transplant 2010; 25:1524-1531.
47. O'Leary JG, Davis GL. Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease. Liver Transpl 2009; 15:1325-1329.
48. Wright WL, Asbury WH, Gilmore JL, Samuels OB. Conivaptan for hypona tremia in the neurocritical care unit. Neurocrit Care 2009; 11:6-13.
49. Murphy T, Dhar R, Diringer M. Conivaptan bolus dosing for the correction of hyponatremia in theneurointensive care unit. Neurocrit Care 2009; 11:14-19.